Literature DB >> 11398309

Migraine and coeliac disease.

J Serratrice1, P Disdier, C de Roux, C Christides, P J Weiller.   

Abstract

The pathophysiology of migraine remains unclear. To incriminate a comorbid factor is always hypothetical, even if suppression of this factor appears to prevent the migrainous attacks. In our patient, treatment of coeliac disease coincided with total disappearance of severe migraine attacks. Moreover, the coeliac disease was first revealed during the evaluation of a migraine with aura.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 11398309     DOI: 10.1046/j.1526-4610.1998.3808627.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  10 in total

Review 1.  A Clinical Approach to Addressing Diet with Migraine Patients.

Authors:  Margaret Slavin; Jessica Ailani
Journal:  Curr Neurol Neurosci Rep       Date:  2017-02       Impact factor: 5.081

2.  A case-control study of presentations in general practice before diagnosis of coeliac disease.

Authors:  Rebecca Cannings-John; Christopher C Butler; Hayley Prout; Diane Owen; Della Williams; Kerenza Hood; Rosemary Crimmins; Gillian Swift
Journal:  Br J Gen Pract       Date:  2007-08       Impact factor: 5.386

Review 3.  Gastrointestinal Headache; a Narrative Review.

Authors:  Majid T Noghani; Hossein Rezaeizadeh; Sayed Mohammad Baqer Fazljoo; Mansoor Keshavarz
Journal:  Emerg (Tehran)       Date:  2016-11

Review 4.  Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm.

Authors:  Giuseppe Losurdo; Mariabeatrice Principi; Andrea Iannone; Annacinzia Amoruso; Enzo Ierardi; Alfredo Di Leo; Michele Barone
Journal:  World J Gastroenterol       Date:  2018-04-14       Impact factor: 5.742

5.  Headache Associated with Coeliac Disease: A Systematic Review and Meta-Analysis.

Authors:  Panagiotis Zis; Thomas Julian; Marios Hadjivassiliou
Journal:  Nutrients       Date:  2018-10-06       Impact factor: 5.717

Review 6.  Gut-brain Axis and migraine headache: a comprehensive review.

Authors:  Mahsa Arzani; Soodeh Razeghi Jahromi; Zeinab Ghorbani; Fahimeh Vahabizad; Paolo Martelletti; Amir Ghaemi; Simona Sacco; Mansoureh Togha
Journal:  J Headache Pain       Date:  2020-02-13       Impact factor: 7.277

7.  STOP 301: A Phase 3, open-label study of safety, tolerability, and exploratory efficacy of INP104, Precision Olfactory Delivery (POD® ) of dihydroergotamine mesylate, over 24/52 weeks in acute treatment of migraine attacks in adult patients.

Authors:  Timothy R Smith; Paul Winner; Sheena K Aurora; Maria Jeleva; Jasna Hocevar-Trnka; Stephen B Shrewsbury
Journal:  Headache       Date:  2021-08-07       Impact factor: 5.311

Review 8.  Gastrointestinal disorders associated with migraine: A comprehensive review.

Authors:  Carlos R Cámara-Lemarroy; Rene Rodriguez-Gutierrez; Roberto Monreal-Robles; Alejandro Marfil-Rivera
Journal:  World J Gastroenterol       Date:  2016-09-28       Impact factor: 5.742

9.  A Survey on Migraine Prevalence in Patients with Inflammatory Bowel Disease - A Single Centre Experience.

Authors:  Somaye Chehel Cheraghi; Nasser Ebrahimi Daryani; Mojdeh Ghabaee
Journal:  Middle East J Dig Dis       Date:  2016-10

Review 10.  A link between gastrointestinal disorders and migraine: Insights into the gut-brain connection.

Authors:  Sheena K Aurora; Stephen B Shrewsbury; Sutapa Ray; Nada Hindiyeh; Linda Nguyen
Journal:  Headache       Date:  2021-04-01       Impact factor: 5.887

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.